Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.37M 1.24M 2.33M 157M 2.36M 16.38M 6.3M 80.41M 6.16M 6.03M 258M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.16M 6.78M 6.12M 11.54M 779M 11.69M 81.15M 31.23M 398M 30.52M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
-0.03%+3.00%+55.37%+120.23% 1,056B
-0.13%-0.78%+44.04%+72.14% 645B
+0.11%-0.66%+13.73%+77.62% 465B
-1.67%-1.03%+74.61%+42.91% 368B
-0.06%-3.88%+34.32%+40.74% 335B
-0.79%+2.01%+19.82%+28.48% 275B
-1.19%-1.21%+9.82%+12.15% 255B
-0.08%+3.90%+49.51%+58.43% 229B
-0.57%-0.77%+35.32%+102.70% 188B
Average +989.60%+0.11%+33.65%+55.54% 381.58B
Weighted average by Cap. -0.34%+0.30%+41.45%+74.07%

Financials

2007 2008
Net sales 23.47M 20.66M 19.58M 17.68M 33.31M 2.25B 33.74M 234M 90.15M 1.15B 88.12M 86.19M 3.69B 25.96M 22.86M 21.66M 19.55M 36.85M 2.49B 37.33M 259M 99.72M 1.27B 97.48M 95.35M 4.08B
Net income -20.86M -18.37M -17.4M -15.71M -29.61M -2B -29.99M -208M -80.13M -1.02B -78.32M -76.61M -3.28B -4.01M -3.53M -3.34M -3.02M -5.69M -384M -5.76M -39.99M -15.39M -196M -15.04M -14.71M -630M
Net Debt 18.79M 16.55M 15.68M 14.15M 26.68M 1.8B 27.02M 188M 72.18M 921M 70.56M 69.02M 2.95B 6.49M 5.71M 5.41M 4.89M 9.21M 622M 9.33M 64.77M 24.93M 318M 24.36M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock